AstraZeneca PLC (AZN)

AZN (NYSE:Drugs)
pos +0.00
Today's Range: 69.17 - 70.32 | AZN Avg Daily Volume: 2,495,900
Last Update: 10/24/14 - 4:00 PM EDT
Volume: 0
YTD Performance: 18.11%
Open: $0.00
Previous Close: $69.35
52 Week Range: $52.08 - $82.68
Oustanding Shares: 1,262,751,186
Market Cap: 87,571,794,749
6-Month Chart
TheStreet Ratings Grade for AZN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 1 1 1
Moderate Buy 0 0 0 0
Hold 2 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.33 3.00 3.00 3.00
Latest Dividend: 0.90
Latest Dividend Yield: 4.14%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 33.24
Price Earnings Comparisons:
AZN Sector Avg. S&P 500
33.24 43.30 28.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.90% 34.90% 44.28%
Revenue -8.10 -0.23 -0.08
Net Income -59.40 -0.68 -0.31
EPS -59.10 -0.64 -0.28
Earnings for AZN:
Revenue 25.71B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.04 $0.88 $4.45 $4.18
Number of Analysts 1 1 4 4
High Estimate $1.04 $0.88 $4.55 $4.25
Low Estimate $1.04 $0.88 $4.39 $4.05
Prior Year $1.21 $1.23 $5.05 $4.45
Growth Rate (Year over Year) -14.05% -28.46% -11.83% -6.06%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Americans are living much longer these days -- and there are a number of ways to invest.
Shares nosedived in after-hours trading.
Stop picking on PepsiCo, Allergan and Apple.

This Morning's Market Setup Real Money Pro($)

Where it began.
Each of these 'real' American firms is now a buyout candidate because of the ridiculous U.S. tax code.
You're looking at one.
May 21, 2014 | 8:17 AM EDT
AZN raised its numbers, according to Barclays. Driven by contribution from pipeline products to push sakes growth. $40 price target and...
Across all sectors, stocks are rising in tandem with rates -- but I think this stupidity will end soon.

AstraZeneca Zigs and Zags Real Money Pro($)

The shares have more moves than a shortstop batting .110.

Columnist Conversations

GS has cleared the important hurdle on the way up which increases the odds for an eventual rally towards the 1...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher. CLMS was up about ...
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sending the stock up about...
Market posting decent day considering Ebola getting headlines again. Believe investors have learned not to pa...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.